• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美喹多司在大鼠静脉注射和口服给药后的药代动力学及其代谢物。

Pharmacokinetics of mequindox and its metabolites in rats after intravenous and oral administration.

机构信息

Laboratory of Veterinary Pharmacology, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, PR China.

出版信息

Res Vet Sci. 2012 Dec;93(3):1380-6. doi: 10.1016/j.rvsc.2012.02.015. Epub 2012 Mar 28.

DOI:10.1016/j.rvsc.2012.02.015
PMID:22459092
Abstract

Pharmacokinetics of mequindox (MEQ) and its metabolites were determined in rats after intravenous (i.v.) and oral (p.o.) administration of MEQ at a single dose of 10 mg kg(-1) bodyweight. After both administrations, MEQ and five of its metabolites were quantified, except M4, whereas M1 and M2 were the predominant ones. The areas under the concentration-time curves (h ng mL(-1)) of MEQ, M1, M2, M3, M5 and M10 after i.v. administration were 7559±495, 6354±2761, 5586±2337, 1034±160, 2370±791 and 1813±622, respectively, whereas after p.o. administration, remained as 2809±40, 4361±3544, 4351±1046, 1444±814, 3864±305 and 1213±569, respectively. The elimination half-lives (h) of these compounds after i.v. administration were 3.48±0.80, 4.20±0.76, 6.25±2.41, 4.77±1.54, 4.69±1.62 and 16.89±5.15, respectively, and were 3.21±0.40, 3.66±1.06, 4.20±1.03, 8.91±5.99, 4.20±2.02 and 20.84±10.85 after p.o. administration, respectively. After p.o. administration, the bioavailability of MEQ was 37.16%. The results showed that MEQ was extensively metabolized in rats and rapidly absorbed after p.o. administration.

摘要

给鼠单剂量 10mg/kg 静脉(i.v.)和口服(p.o.)给予马兜铃酸美喹多星(MEQ)后,测定 MEQ 及其代谢物的药代动力学。两种给药途径后,除 M4 外,均定量检测到 MEQ 和其 5 种代谢物,其中 M1 和 M2 为主要代谢物。i.v.给药后 MEQ、M1、M2、M3、M5 和 M10 的浓度-时间曲线下面积(h·ng·mL-1)分别为 7559±495、6354±2761、5586±2337、1034±160、2370±791 和 1813±622,而 p.o.给药后分别为 2809±40、4361±3544、4351±1046、1444±814、3864±305 和 1213±569。i.v.给药后这些化合物的消除半衰期(h)分别为 3.48±0.80、4.20±0.76、6.25±2.41、4.77±1.54、4.69±1.62 和 16.89±5.15,而 p.o.给药后分别为 3.21±0.40、3.66±1.06、4.20±1.03、8.91±5.99、4.20±2.02 和 20.84±10.85。p.o.给药后 MEQ 的生物利用度为 37.16%。结果表明,MEQ 在大鼠体内广泛代谢,p.o.给药后迅速吸收。

相似文献

1
Pharmacokinetics of mequindox and its metabolites in rats after intravenous and oral administration.美喹多司在大鼠静脉注射和口服给药后的药代动力学及其代谢物。
Res Vet Sci. 2012 Dec;93(3):1380-6. doi: 10.1016/j.rvsc.2012.02.015. Epub 2012 Mar 28.
2
Pharmacokinetics of mequindox and one of its major metabolites in chickens after intravenous, intramuscular and oral administration.美喹多司在鸡体内静脉注射、肌肉注射和口服后的药代动力学及其一种主要代谢物。
Res Vet Sci. 2012 Aug;93(1):374-7. doi: 10.1016/j.rvsc.2011.07.007. Epub 2011 Aug 11.
3
Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.给小鼠和大鼠静脉注射DA - 125或ME2303后M1、M2、M3和M4的药代动力学比较。含氟的新型阿霉素类似物。
Biopharm Drug Dispos. 1996 Jul;17(5):373-420. doi: 10.1002/(SICI)1099-081X(199607)17:5<373::AID-BDD373>3.0.CO;2-U.
4
Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.胆固醇酯转移蛋白抑制剂托彻普(torcetrapib)在大鼠、猴子和小鼠体内的代谢、药代动力学及排泄:利用高分辨率液相色谱 - 串联质谱和¹H核磁共振对异常及新型代谢物的表征
Drug Metab Dispos. 2008 Oct;36(10):2064-79. doi: 10.1124/dmd.108.022277. Epub 2008 Jul 24.
5
Identification of ginkgolic acid (15:1) metabolites in rats following oral administration by high-performance liquid chromatography coupled to tandem mass spectrometry.高效液相色谱-串联质谱法鉴定大鼠口服给药后银杏酸(15:1)的代谢产物
Xenobiotica. 2013 May;43(5):454-60. doi: 10.3109/00498254.2012.725141. Epub 2012 Dec 4.
6
Metabolism, Distribution, and Elimination of Mequindox in Pigs, Chickens, and Rats.乙酰甲喹在猪、鸡和大鼠体内的代谢、分布及排泄
J Agric Food Chem. 2015 Nov 11;63(44):9839-49. doi: 10.1021/acs.jafc.5b02780. Epub 2015 Oct 30.
7
New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.秋水仙碱硫代衍生物及其活性代谢产物在健康人体中的新代谢和药代动力学特征。
Fundam Clin Pharmacol. 2004 Aug;18(4):493-501. doi: 10.1111/j.1472-8206.2004.00277.x.
8
Absorption and enterohepatic circulation of baicalin in rats.大鼠体内黄芩苷的吸收及肠肝循环
Life Sci. 2005 Nov 26;78(2):140-6. doi: 10.1016/j.lfs.2005.04.072. Epub 2005 Aug 16.
9
Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.氟苯尼考及其代谢产物氟苯尼考胺在犬体内的药代动力学。
Res Vet Sci. 2008 Feb;84(1):85-9. doi: 10.1016/j.rvsc.2007.04.001. Epub 2007 Jun 13.
10
Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.新型血管紧张素转换酶抑制剂咪达普利在动物体内的代谢命运。第6篇通讯:大鼠、犬和猴体内咪达普利代谢产物的药代动力学及排泄的种间比较
Arzneimittelforschung. 1992 Apr;42(4):499-506.

引用本文的文献

1
The Reproductive Toxicity of Mequindox in a Two-Generation Study in Wistar Rats.喹乙醇在Wistar大鼠两代研究中的生殖毒性
Front Pharmacol. 2018 Aug 17;9:870. doi: 10.3389/fphar.2018.00870. eCollection 2018.
2
UPLC-MS/MS Method for Simultaneous Determination of Three Major Metabolites of Mequindox in Holothurian.超高效液相色谱-串联质谱法同时测定海参中喹烯酮三种主要代谢物
J Anal Methods Chem. 2018 Apr 1;2018:2768047. doi: 10.1155/2018/2768047. eCollection 2018.
3
Mechanisms of the Testis Toxicity Induced by Chronic Exposure to Mequindox.
长期接触喹烯酮所致睾丸毒性的机制
Front Pharmacol. 2017 Sep 26;8:679. doi: 10.3389/fphar.2017.00679. eCollection 2017.
4
Pharmacokinetics and Metabolism of Cyadox and Its Main Metabolites in Beagle Dogs Following Oral, Intramuscular, and Intravenous Administration.喹乙醇及其主要代谢产物在比格犬口服、肌肉注射和静脉注射后的药代动力学与代谢
Front Pharmacol. 2016 Aug 3;7:236. doi: 10.3389/fphar.2016.00236. eCollection 2016.